莫德纳和默克股价重挫,黑色素瘤疫苗数据未能惊艳市场

智通财经
6 hours ago
【莫德纳和默克股价重挫,黑色素瘤疫苗数据未能惊艳市场】莫德纳和默克股价下跌,两家公司备受期待的个性化黑色素瘤疫苗数据不足以让投资者相信癌症治疗的新时代已经到来。两家公司8月宣布,这款定制疫苗如与默克畅销药Keytruda联合使用,可显著降低这种致命肿瘤的复发风险,并具有临床意义。周四泄露的完整试验数据未能达到华尔街今年早些时候形成的高预期。尽管实验结果清楚表明疫苗有效,但没有惊艳到足以让市场相信莫德纳和默克能够实现更宏大的目标,即开创一种治疗多种癌症的新方法。莫德纳股价重挫18%,默克下跌1.8%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10